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Abstract 
Vibrio cholerae O1 infections mainly are responsible for significant mortality and morbidity 
amongst children, however, non-O1/non-O139 V. cholerae have also been reported to cause mild 
to severe infections because of their virulence potential. The pathogenic mechanisms of non-O1, 
non-O139 isolates are not as clearly understood as for that of O1 and O139 isolates. Type three 
secretion system (TTSS) is also considered one of the important virulent factors and during the 
current study, we investigated the role of TTSS in association with non-O1/non-O139 clinical 
isolates. We report that the presence of TTSS in non-O1/non-O139 V. cholerae clinical isolate 
(D13) from a child confers more virulence compared to the one lacking it (D15) in another 
clinical case during the small cholera epidemic. Moreover, the antibiotic susceptibility profiles of 
D13 and D15 indicate that they are multiple drug resistance (MDR) isolates. The sequence 




















reference Vibrio parahaemolyticus RIMD2210633 and V. cholerae AM19226 non-O1/non-
O139.  Furthermore, the pathogenic potential of D13 & D15  was also explored in simple and 
economical invertebrate host model, Galleria mellonella and the results revealed that TTSS+ve
isolate (D13) was more virulent compared to TTSS
-ve
 isolate (D15). We suggest that this distinct 
genetic difference, seen in natural variants D13 and D15, is also reflected by the clinical picture 
of the former in contributing towards the severity of disease symptoms and this finding was 
further validated by assessing virulence potential of both isolates using inexpensive G. 
mellonella infection model. 
1. Introduction 
 Vibrio cholerae, a gram-negative bacterium, belonging to the -subdivision of the family 
proteobacteriaceae causes acute watery diarrheal disease known as cholera [1]. Cholera has 
claimed millions of lives in the past, but today cholera is still endemic in Africa and South Asia 
where it has been reported for at least 1,000 years [2]. Cholera is mostly a disease of the tropics, 
it is often associated with low quality sanitation management where the people had limited 
access to microbiologically safe drinking water. Natural calamities such as floods, earthquakes, 
and political disturbances resulting in wars, also increase the likelihood of a cholera epidemic. V. 
cholerae is a highly heterogenous species, based on somatic O antigen >200 serogroups exists, 
the majority of which are non-pathogenic and only O1 and O139 out of 200 serogroups are 
known to cause widespread and repeated epidemics. The O1 and O139 can be further subdivided 
into two biotypes, El Tor and classical [3-4].  
              Seven cholera pandemics have been recorded since 1817. It is widely accepted that the 
first six epidemics are caused by biotype: classical, while the current seventh pandemic was due 




















increasingly recognized as a cause of sporadic cases of gastroenteritis usually resulting in severe 
bloody diarrhea and are also associated with extra-intestinal infections including bacteremia, skin 
and wound infections in immuno-compressed individuals [5-6]. 
V. cholerae O1, O139, and non-O1/non-O139 serogroups differ in their clinical outcome 
because of the number of virulence factors ranging from array of toxins, colonization factors, 
antibiotic resistance, resistance to disinfectant provided by capsular polysaccharides, as well as 
unique surface antigens (O139 lipopolysaccharide and O antigen capsule) [7-10].  
 In different parts of Africa, USA, Asia, and Europe cholera outbreaks were recorded and 
their studies [11-12] revealed that V. cholerae non-O1/non-O139 strains are the causative agent 
of these outbreaks. Some of these isolates although non-pandemic serogroups possess known 
genes/systems associated with virulence including the cholera toxin phage (CTX), genomic 
islands VSP-1 and 2, and VPI-1 and 2. However, even without typically associated virulence 
factors with O1 and O139 serogroup isolates  such as cholera toxin (CT),  carried by CTX and 
TCP genes required for human intestinal colonization, additional virulence factors comprising 
heat-stable enterotoxin (ST), haemolysin (HlyA), mannose-sensitive hemagglutinin (MSHA) 
pilus, repeats in toxin (RTX), and the type three secretion system (TTSS) enhance virulence of 
non-agglutinating vibrios (NAGs) i.e.non-O1/non-O139 isolates [13-17]. 
 Previous studies revealed that the non-O1/non-O139 V. cholerae strain AM-19226 
successfully colonized the infant mouse intestine as well as induced a cholera-like disease 
condition in adult rabbits [17-18]. The genome analysis of AM-19226 further revealed that it 
lacked CT and TCP suggesting that perhaps other virulence factors including type III secretion 
system (TTSS) may have compensated for the lack of CT and TCP in infant mouse and rabbit 




















non-O1/non-O139 V. cholerae isolates of both clinical and environmental origins [19-20, 23- 
24].  They facilitate direct translocation of TTSS secreted effectors proteins through a syringelike 
a needle into the host cytosol [19-20]. The translocated effector proteins are known to interfere 
cellular processes including depolymerization of cytoskeleton components [21] and more 
specifically the products of factors such as opF, vopE, stimulates actin nucleation and promotes 
actin depolymerization respectively [22].    
 The genome analysis of non-O1/non-O139 TTSS shows strong homology to V. 
parahaemolyticus TTSS gene clusters [17] and have been proposed to play a role in virulence 
and environmental adaptation of these isolates [17]. However, the significance of TTSS 
particularly in association with human non-O1/non-O139 V. cholerae and other less 
characterized effectors in the pathogenesis of the diarrheal disease is not well understood.  
            We identified two non-O1/non-O139 V. cholerae isolates from children under 10 years of 
age showing cholera-like symptoms and, investigated their susceptibility profiles as well the 
virulence potential of the isolates with a focus on TTSS. This is the first report where TTSS in 
association with non-O1/non-O139 V. cholerae clinical cases was investigated from Pakistan and 
we believe a greater understanding of the differences between pandemic and non-pandemic 
serogroups will have implications for our better monitoring and surveillance of V. cholerae in the 
future.  
2. Material and methods 
2.1 Ethical statement           





















2.2 Sample collection and identification: 
  
  Suspected cholera stool samples were collected in Cary-Blair transport medium within 24 
hours of the patient being admitted and transported to Microbiology & Public Health Laboratory 
at Department of Biosciences, COMSATS University  Islamabad.  For enrichment of samples, 
1x alkaline peptone water was used after 6-8 hrs incubation at 37°C. After enrichment, the 
inoculum was taken and smeared on solid thiosulfate citrate bile salts (TCBS)  sucrose medium 
and then it was placed at 37°C for 16-20 hrs and yellowish-green colonies, characteristic of 
Vibrio species, were selected and biochemical and molecular tests were performed as described 
previously [21-22].  Isolates were preserved in BHI broth at -8°C containing 20% glycerol.  
2.3 Serotyping  determination 
     
           Slide agglutination test was carried out to confirm if the isolates belonged to O1 and O139 
serogroups or non-O1/non-O139. Monovalent Inaba and Ogawa antisera and Polyvalent Inaba 
and Ogawa antisera (Denka Seiken, Japan) were used to determining serogroup O1. The 
serogroup specific encoding regions were amplified by multiplex PCR [25].  
2.4 Antimicrobial susceptibility test 
  
  According to CLSI guideline (CLSI, 2009) [26], antimicrobial susceptibility to different 
antibiotics was checked by Kirby Bauer disc diffusion tests on Muller-Hinton Agar (Oxoid). The 
antibiotics used were: trimethoprim (25 µg), tetracycline (30 µg), ampicillin (10 µg), 
sulfamethoxazole/trimethoprim (23.71/1.25 µg), erythromycin (15 µg), streptomycin (10 µg), 
ofloxacin (5 µg), nalidixic acid (30 µg), ceftazidime (30 µg), ciprofloxacin (5 µg), cefotaxime 





















2.5 DNA extraction and genomic characterization of D13 and D15 
 Overnight culture of V. cholerae D13 (isolate from 9 year old child) and D15 (isolate 
from 10 year  old child) isolates in nutrient broth was used to extract DNA by ArchiPure DNA 
extraction Kit (Prime 5, UK). PCR was performed to screen for rtxA and ompW  [27, 28]. 
Further, screening through PCR using various gene specific primers was carried out for detecting 
virulence factors i.e. tcpA, ctxA, TTSS (vcsC, vspD, vcsV) (Table 1). 
2.6 Genetic characterization of antibiotic resistance 
  
The isolated strains were analyzed by PCR to detect conjugative and integrative element  
SXT [29], integrons [30], and genetic basis for resistance to sulfamethoxoles [31-32], 
fluoroquinolones [33-34], streptomycin [35-36], chloramphenicol [36] and trimethoprim.  
Table 1: Primers used in the study 





rtxA F: AGCAAGAGCATTGTTGTTCCTACC 
R:  ACTTCCCTGTACCGCACTTAGAC 
61 120 [27] 
ompW F: CACCAAGAAGGTGACTTTATTGTG 
R: GAACTTATAACCACCCGCG 
61 588 [28] 
ctxA F: CTCAGACGGGATTTGTTAGGCACG 
R: TCTATCTCTGTAGCCCCTATTACG 
60 301 [37] 
O1 rfb F:  GTTTCACTGAACAGATGGG 
R: GGTCATCTGTAAGTACAAC 
55 192 [25] 
O139 rfb F: AGCCTCTTTATTACGGGTGG 
R: GTCAAACCCGATCGTAAAGG 
55 449 [25] 
tcpA
Cl
 F: CACGATAAGAAAACCGGTCAAGAG 
R: ACCAAATGCAACGCCGAATGGAGC 
60 472 [37] 
tcpA
ET
 F: GAAGAAGTTTGTAAAAGAAGAACAC 
R: GAAAGGACCTTCTTTCACGTTG 
60 672 [37] 
vcsC2 F:CGTCGACGTTACCGATGCTATGGGT 
R:GCTCTAGAAGTCGGTTGTTTCGGTAA 
60 535 [42] 
vcpD F:CGTCGACAGTTGAGCCAATTCCATT 
R:AGACGACCAAACGAGATAATG 
55 422 [17] 
vcsV2 F:ATGCAGATCTTTTGGCTCACTTGATGG 
R:ATGCGTCGACGCCACATCATTGCTTGC 




















2.7 Genome sequencing of D13 and D15 
 
D13 and D15 isolates were sequenced by Illumina HiSeq platform. Initially by creating 
multiplex sequencing libraries were created each with  250 bps capacity. To get paired end reads 
of 72 bases of 96 libraries, libraries were loaded on the sequencing platform cell. Unique index 
tagging was used to labeled each library. For both samples 200X- average coverage was 
achieved and using a de novo genome assembly program Velvet version 0.7 [44], the 72 bps 
paired end reads were assembled. For best k-mer size and at least 20×k-mer coverage, 
parameters were set to appropriate values. By using SMALT software, genome of V. cholerae
O1 El Tor strain N16961 is mapped to the 72-base paired end read data of both isolates and 
whole genome alignment of both isolates was obtained. The data was used to predict and 
compare TTSS cluster with reference sequences (RIMD2210633; AM19226). 
2.8 Type three secretion system (TTSS) prediction and comparison 
 
The TTSS gene cluster in V. cholerae D13 and D15 genome sequences were predicted 
using BLAST [45]. V. cholerae AM19226 was taken as the reference sequence against which V. 
cholerae D13 and D15 genomes were queried. BLAST comparisons among the multiple 
genomic regions of interest were further visualized using Easyfig [46].  
2.9. Genome Comparison of D13 & D15 
To do the annotation of both D13 and D15, the genome sequences of both strains had 




















2.10 Galleria mellonella infection model for clinical non-O1/non-O139 V. Cholera 

 To investigate the virulence potential of TTSS positive and negative clinical non-O1/non-
O139 V. cholerae isolates, infection assays were performed by using an invertebrate model 
system, Galleria mellonella as described previously [47, 48]. Briefly, 10 l taken from overnight 
(O/N) culture, grown at 30°C carrying 10
4
 CFU to 10
8
 CFU were injected into first right proleg 
of G. melonella larvae. 10 larvae were injected in each case. 70% (vol/vol) ethanol was used for 
surface disinfection, and experimental models were scored at 24 and 48 hours for phenotypes 
such as survival, movement and change in color. In parallel, PBS diluent was injected to control 
larvae and the experiment considered successful when no control larvae died. Larvae which 
show no movement/response when touched were considered dead. Data from at least three 
replicates was analyzed and for each strain, 50% lethal doses were calculated.  
3. Results 





 non-O1/non-O139 isolates 
  
This study is based on two child patients presenting cholera-like illness. On the basis of 
standard biochemical tests and PCR, stool sample of both patients were considered positive for 
presence of V. cholerae [28, 49]. Briefly, cholera isolate-D13 was isolated from a 9 year old 
male patient admitted to pediatric ward of civil hospital, Dera Ismail Khan (Khyber Pukhtoon 
Khwa province) with symptoms of watery stool accompanied with fever (102°F), concomitant 
with episodes of vomiting, severe dehydration and frequent passage of watery stools (Isolate-
D13). The second isolate (Isolate-D15) was taken from a 10 year old male patient with profuse 




















Serogroup determination by using slide agglutination test revealed that V. cholerae
isolates (D13 and D15) belonged to non-O1/non-O139 serogroups as they lack O1rfb/O139rfb or 
tcpACl/tcpAEl the latter was confirmed by separate multiplex PCRs. PCR also showed both 
isolates lacked the cholera toxin and the cholera prophage encompassing genes ctxA, zot, ace and 
RS1. These isolates also lacked tcpA, an important virulence factor located on vibrio 
pathogenicity island -1. However, using TTSS gene -specific primers (Table 1), D13 was found 
positive for TTSS (Figure 1.) 
Figure 1: Detection of TTSS in D-13. 
3.2 Genotypic and Phenotypic characterisation of antimicrobial resistance in D13 and D15 
D13 and D15 were multiple drug resistant as they exhibited resistance phenotypes for 
streptomycin, co-trimoxazole, nalidixic acid and ciprofloxacin on Mueller-Hinton (MH) agar. 
However, resistance to ceftazidime and ofloxacin varied as D13 was resistant to ceftazidime 
whereas D15 to ofloxacin. Response to tetracycline, erythromycin and ceftaxime were 




















Integrons of all three classes were absent in D13 and D15 as consensus sequences of their 
integrases were not amplified by PCR. Integrative and conjugative element, SXT was not found  
in these isolates. strA and strB (encoding streptomycin resistance) were present as the PCR 
revealed amplification of 284 and 248 bps fragments respectively whereas in case of 
sulfamethoxazole resistance encoding genes, sul2 was present and sul1 and sul3 were absent. 
Furthermore, qnrA, qnrB and qnrS (fluoroquinoles resistance) were not present in D13 and D15. 
Among, other antibiotic resistance encoding genes, florR (chloramphenicol resistance) was only 
present in D15. (Table 2)  






encoding genes present 
Antimicrobial resistance encoding elements not 
detected 
D13 sul2, strA, strB, SXT, dfrA1, dfrA18, tetA, , qnrA, qnrB, qnrS , sul1, sul3,
intI, int2, int3,  florR
D15 sul2, strA, strB, florR SXT, dfrA1, dfrA18, tetA , qnrA, qnrB, qnrS, sul1, sul3,
intI, int2, int3. 
3.3 TTSS comparative sequence analysis 
The conserved TTSS gene cluster in the assembled completed genomes of V. cholerae
D13 and D15 was identified based on similarity searches through BLAST. The alignment results 
confirmed the existence of TTSS cassette  in  D13 isolate while it was not found in the genome 
D15 isolate. Comparative analysis results of the conserved TTSS genes cluster of V. 
parahaemolyticus RIMD2210633, V. cholerae AM19226, and V. cholerae D13 were visualized 
and shown in Figure 2. The result from TTSS gene cluster genome alignment has also shown the 




















Figure 2. Comparison of TTSSs gene cluster of genomes of V. parahaemolyticus
RIMD2210633, V. cholerae AM19226, and V. cholerae D13. Arrows represent TTSS CDSs 
which comes through BLAST hits and  annotation. Vertical lines between sequences show 
regions  having shared homology . 
  
3.4. Genome Comparison of D13 & D15 
In general, both genomes (D13 and D15) showed the similar number of genes that have 
been annotated. The genome statistic also showed the similar characters. The results of analysis 
are shown as in Appendix A (Figures A1 & A2).
3.5 Mortality in G. mellonella infected with V. cholerae  TTSS
+ve 
 isolate and TTSS
-ve
  isolate 




 CFU of bacterial cells (D-15 and D-
13) and number of surviving insects were recorded after 24 hrs (A) and 48 hrs (B), and are 
shown in tabular form under the graph. The numbers (CFUs) shown in these results are the mean 
values of three independent experiments. 





 (D15) isolates, we investigated their pathogenicity in G. mellonella larvae. In the 




 CFUs of bacterial cells (D15, D13) were injected, and their 




















compared with PBS injected control group. No mortality of G. mellonella larvae was observed in 
control group. Death of at least 90% larvae was observed due to presence of TTSS+ve strain. 
On the other hand, larvae infected with TTSS-ve strain showed 60% deaths at 104 CFUs, 24 hours 
post injection (Figure 3A). As the dose increased, the number of larval deaths increased, and 
100% larval deaths were recorded at 10
7
 CFUs (Figure 3A) and 10
6
 CFUs (Figure 3B), at 24 hr 
and 48 hr respectively. The number of surviving larvae, injected with TTSS
-ve
 strain, remained 
higher as compared to larvae injected with TTSS
+ve
 strain, regardless of time and dose. (Figure 
3). The comparative percentage of survival results indicates the G. mellonella is more susceptible 
to TTSS
+ve
 non-O1/non-139 V. cholerae.   
Figure 3: Comparison of killing potential of D-15 and D-13 against G. mellonella at different 
doses and time. CFUs, colony forming units.
4. Discussion 
Vibrio cholerae associated with acute watery diarrhea has a substantial prevalence in 
Pakistan, since the disease is endemic in South Asia and some African and South American 
countries [4]. Cholera results in higher morbidity and mortality in children and the elderly 




















observed during monsoon seasons often resulting in floods contaminating water reservoirs with 
cargo pathogens including V. cholerae. V. cholerae has a great variety of serogroups, among 
them only O1 and O139 cause epidemics because these strains encode the cholera toxin and 
other virulent arsenals which are responsible for characteristic cholera symptoms [24]. However, 
the non-O1/non-O139 strains also caused local outbreaks which are increasing day by day due to 
consumption of raw sea food or extra-intestinal infections from recreational waters [50]. 
Furthermore, these strains are acquiring more virulent characteristics which are helpful in 
evolving more pathogenic non-O1/non-O139 isolates posing higher levels of threats.  
In this study, two non-O1/non-O139 V. cholerae associated diarrheal cases with distinct 
clinical picture were analyzed to better understand the pathogenicity based on phenotypic and 
genomic characteristics. The study revealed that both non-O1/non-O139 isolates (D13 and D15) 
lacked the cholera toxin as well as toxin co-regulated pili which are the unique feature of 
toxigenic V. cholerae of O1 and O139 serogroups. However, D13 caused severe acute diarrheal 
disease whereas D15 caused mild diarrhea. Both the isolates possessed rtxA and hemolysin 
(hlyA) as a majority of the non-agglutinating vibrios (nag) from other regions also shown to 
possess hemolysin [38, 39, 41, 42, 51]. Furthermore, both isolates possessed dth (gamma-
thermostable hemolysisn), the product of which is similar to Tdh hemolysin of V. 
parahemolyticus, however dth role in disease has not been clearly elucidated among non-
O1/non-O139 V. cholerae [52]. Moreover, key virulence players such as TcpA from vibrio 
pathogenicity island-1 (VPI-1) as well as other important members of VPI-1 such as toxT, toxR, 
acf, tagA and aldA were not found. Partial or intact VPI-1 were found in some non-O1/non-O139 




















that presence of tcpA or VPI-1 in NAG vibrio may be associated with acquisition of ctx phage in 
shaping up highly virulent non-O1/non-o139 in the environment [53].  
VSP-1 and VSP-II found in the contemporary toxigenic V. cholerae O1 El Tor, usually 
absent in the six pandemic O1 V. cholerae and majority of the non-O1/non-o139 vibrio or 
environmental vibrios [41]. VSP-1 and VSP-2 are rarely present in non-O1/non-O139 isolates as 
majority of the studies did not find these islands in these vibrios or only encode some open 
reading frames in case of their existence [41, 43] and that was the case for D13 and D15 isolates 
as well for current study.  
Both (D13 and D15) the strains showed a multiple antibiotic resistance phenotype with 
resistance to streptomycin, co-trimoxazole, nalidixic acid, ciprofloxacin, ceftaxime and ofloxacin 
compared to some recent studies where non-O1/non-O139 were susceptible to antibiotics [23, 
54]. However, enhanced level of resistance to ampicillin, chloramphenicol, fluoroquinolones, co-
trimoxazole have been reported by many studies [55-57] like the current study. However, the 
resistance pattern of these non-O1/non-O139 isolates was different from O1 isolates of clinical 
origin in Pakistan [58]. Genotypically, integrative and conjugative element (ICE-SXT) was 
absent in these NAG isolates which is now consistently encoded by O1 El tor. In addition,  
mobile genetic elements such as integrons encoding resistance to various antibiotics were non-
existent. However, for chloramphenicol resistance encoding florR was present similarly, 
sulfamethoxazole resistance encoding sul2 was also detected by PCR. The different drug profile 
from those of O1 V. cholerae suggested that empirical antibiotic cholera therapy is relevant for 
non-O1 infections and it must be revised. Moreover,  there is also a threat of an increase in 
antibiotic resistance as, like other reservoirs, the marine and aquatic habitats are also under risk 




















On the other hand, ctxA, ace, zot, mshA, were absent in both isolates investigated during 
the current study. Previous studies also show that non-O1/non-O139 isolates usually do not 
produce cholera toxin unlike  O1 and O139 [60]. However, these non-O1/non-O139 isolates may 
acquire cholera toxin carrying CTX phage and transfer of CTX phage from ctx positive to ctx
negative non-O1/non-O139 isolates [61].  
The genome analysis in the TTSS gene cluster support the similarity of non-O1/non-
O139 TTSS V. cholerae D13 with V. parahaemolyticus TTSS gene cluster [17]. The high 
similarity of TTSS gene cluster and organizations were found among V. cholerae D13 and V. 
parahaemolyticus in comparison with V. cholerae AM 19226. However, some genes are present 
only in V. parahaemolyticus while missing in V. cholerae D13, on the other hand, some genes 
are present only in V. cholerae D13 while missing in V. parahaemolyticus. Galleria melonella
infection model analysis indicated that the presence of TTSS (D13) has contributed in enhancing 
its virulence compared to another non-O1 strain (D15) lacking TTSS and which somehow has 
been corroborated with the clinical picture of the patient as well.  
 At this time, we cannot say exactly what molecular mechanism of pathogenesis lead to 
frequent death of the G. mellonella larvae after infection with TTSS
+ve
 nonO1/nonO139 but it 
may have contributed either directly or indirectly by allowing the production of other virulence 
factors or toxins such as RTX. 
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Type III secretion system confers enhanced virulence in clinical non-O1/non-
O139 Vibrio cholerae
Highlights:
Type three secretion system (TTSS) is also considered one of the important virulent 
factors and during the current study we investigated the role of TTSS in association with 
non-O1/non-O139 clinical isolates. 
This article report that the presence of TTSS in non-O1/non-O139 V. cholerae clinical 
isolate (D13) from a child confers more virulence compared to the one lacking it (D15) in 
another clinical case during the small cholera epidemic. 
The antibiotic susceptibility profiles of D13 and D15 indicate that they are multiple drug 
resistance (MDR) isolates.
The results revealed that that TTSS
+ve




These finding was further validated by assessing virulence potential of both isolates using 
inexpensive G. mellonella infection model.
